Literature DB >> 27227699

Defining adherence to prophylaxis in haemophilia.

L H Schrijvers1, M H Cnossen2, M Beijlevelt-Van der Zande3, M Peters3, M J Schuurmans4,5, K Fischer1,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27227699     DOI： 10.1111/hae.12935

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

Review 1.  Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia.

Authors:  Massimo Morfini; Stefano Gherardini
Journal:  Ther Adv Hematol       Date:  2018-06-05

Review 2.  Categorizing factors of adherence to parenteral treatment in growth hormone deficiencies and hemophilia: What should be the targets for future research?

Authors:  Serge Sultan; Mira El-Hourani; Émélie Rondeau; Nicolas Garnier
Journal:  Patient Prefer Adherence       Date:  2018-10-08       Impact factor: 2.711

3.  The Perspectives of Adolescents and Young Adults on Adherence to Prophylaxis in Hemophilia: A Qualitative Study.

Authors:  J W Hoefnagels; M C Kars; K Fischer; Reg Schutgens; L H Schrijvers
Journal:  Patient Prefer Adherence       Date:  2020-01-23       Impact factor: 2.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.